Abraham N. Oler - Net Worth and Insider Trading

Abraham N. Oler Net Worth

The estimated net worth of Abraham N. Oler is at least $4,652 dollars as of 2024-11-29. Abraham N. Oler is the SVP Corp Dev & Gen Counsel of Traws Pharma Inc and owns about 981 shares of Traws Pharma Inc (TRAW) stock worth over $4,652. Details can be seen in Abraham N. Oler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Abraham N. Oler has not made any transactions after 2022-01-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Abraham N. Oler

To

Abraham N. Oler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Abraham N. Oler owns 1 companies in total, including Traws Pharma Inc (TRAW) .

Click here to see the complete history of Abraham N. Oler’s form 4 insider trades.

Insider Ownership Summary of Abraham N. Oler

Ticker Comapny Transaction Date Type of Owner
TRAW Traws Pharma Inc 2022-01-28 VP Corp Dev & Gen Counsel

Abraham N. Oler Latest Holdings Summary

Abraham N. Oler currently owns a total of 1 stock. Abraham N. Oler owns 981 shares of Traws Pharma Inc (TRAW) as of January 28, 2022, with a value of $4,652.

Latest Holdings of Abraham N. Oler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TRAW Traws Pharma Inc 2022-01-28 981 4.74 4,652

Holding Weightings of Abraham N. Oler


Abraham N. Oler Form 4 Trading Tracker

According to the SEC Form 4 filings, Abraham N. Oler has made a total of 10 transactions in Traws Pharma Inc (TRAW) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Traws Pharma Inc is the acquisition of 60 shares on January 28, 2022, which cost Abraham N. Oler around $2,505.

Insider Trading History of Abraham N. Oler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Abraham N. Oler Trading Performance

GuruFocus tracks the stock performance after each of Abraham N. Oler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Abraham N. Oler is 76.6%. GuruFocus also compares Abraham N. Oler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Abraham N. Oler within 3 months outperforms 4 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Abraham N. Oler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Abraham N. Oler

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 22.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 22.27 LIMIT LIMIT LIMIT LIMIT LIMIT

Abraham N. Oler Ownership Network

Ownership Network List of Abraham N. Oler

No Data

Ownership Network Relation of Abraham N. Oler

Insider Network Chart

Abraham N. Oler Owned Company Details

What does Traws Pharma Inc do?

Who are the key executives at Traws Pharma Inc?

Abraham N. Oler is the VP Corp Dev & Gen Counsel of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , Chief Medical Officer Steven M Fruchtman , and Chief Medical Officer Gelder Mark S. Md .

Traws Pharma Inc (TRAW) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Traws Pharma Inc Insider Transactions

No Available Data

Abraham N. Oler Mailing Address

Above is the net worth, insider trading, and ownership report for Abraham N. Oler. You might contact Abraham N. Oler via mailing address: C/o Spectrum Pharmaceuticals, 11500 South Eastern Avenue, Suite 240, Henderson Nv 89052.

Discussions on Abraham N. Oler

No discussions yet.